# Kinetik Holdings Inc.: financial statements, quarterly

KNTK · NYSE · CIK 1692787 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/kntk.md) · [Financials](/companies/kntk/financials.md) · [Filings](/companies/kntk/filings.md) · [Insiders](/companies/kntk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/kntk/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [330](/filings/0001692787-24-000052.md) | [349 d](/filings/0001692787-26-000048.md) | [341](/filings/0001692787-25-000027.md) | [359](/filings/0001692787-25-000050.md) | [396](/filings/0001692787-25-000067.md) | [386 d](/filings/0001692787-26-000048.md) | [443](/filings/0001692787-26-000092.md) | [427](/filings/0001692787-26-000116.md) | [464](/filings/0001692787-25-000067.md) | [430 d](/filings/0001692787-26-000048.md) | [410](/filings/0001692787-26-000092.md) | [581](/filings/0001692787-26-000116.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [38.4](/filings/0001692787-24-000052.md) | [56.1 d](/filings/0001692787-26-000048.md) | [26.1](/filings/0001692787-25-000027.md) | [56.6](/filings/0001692787-25-000050.md) | [72.9](/filings/0001692787-25-000067.md) | [23.7 d](/filings/0001692787-26-000048.md) | [19.3](/filings/0001692787-26-000092.md) | [77.5](/filings/0001692787-26-000116.md) | [19.8](/filings/0001692787-25-000067.md) | [48.4 d](/filings/0001692787-26-000048.md) | [(3.8)](/filings/0001692787-26-000092.md) | [134](/filings/0001692787-26-000116.md) |
| Income tax | $m | [1.3](/filings/0001692787-24-000052.md) | [(235) d](/filings/0001692787-26-000048.md) | [3.8](/filings/0001692787-25-000027.md) | [9.2](/filings/0001692787-25-000050.md) | [8.3](/filings/0001692787-25-000067.md) | [1.8 d](/filings/0001692787-26-000048.md) | [2.6](/filings/0001692787-26-000092.md) | [7.3](/filings/0001692787-26-000116.md) | [1.1](/filings/0001692787-25-000067.md) | [39.7 d](/filings/0001692787-26-000048.md) | [(0.8)](/filings/0001692787-26-000092.md) | [14.4](/filings/0001692787-26-000116.md) |
| Net income | $m | [215](/filings/0001692787-24-000052.md) | [(321) d](/filings/0001692787-26-000048.md) | [234](/filings/0001692787-24-000034.md) | [37.2](/filings/0001692787-25-000050.md) | [25.8](/filings/0001692787-25-000067.md) | [5.5 d](/filings/0001692787-26-000048.md) | [6.1](/filings/0001692787-26-000092.md) | [23.6](/filings/0001692787-26-000116.md) | [5.3](/filings/0001692787-25-000067.md) | [143 d](/filings/0001692787-26-000048.md) | [(1.7)](/filings/0001692787-26-000092.md) | [49.5](/filings/0001692787-26-000116.md) |
| Diluted EPS | $ per share | [0.21](/filings/0001692787-24-000052.md) | not reported | [0.12](/filings/0001692787-25-000027.md) | [0.54](/filings/0001692787-25-000050.md) | [0.35](/filings/0001692787-25-000067.md) | not reported | [0.05](/filings/0001692787-26-000092.md) | [0.33](/filings/0001692787-26-000116.md) | [0.03](/filings/0001692787-25-000067.md) | not reported | [(0.07)](/filings/0001692787-26-000092.md) | [0.64](/filings/0001692787-26-000116.md) |
| Basic EPS | $ per share | [0.21](/filings/0001692787-24-000052.md) | not reported | [0.12](/filings/0001692787-25-000027.md) | [0.54](/filings/0001692787-25-000050.md) | [0.35](/filings/0001692787-25-000067.md) | not reported | [0.05](/filings/0001692787-26-000092.md) | [0.33](/filings/0001692787-26-000116.md) | [0.03](/filings/0001692787-25-000067.md) | not reported | [(0.07)](/filings/0001692787-26-000092.md) | [0.65](/filings/0001692787-26-000116.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.1](/filings/0001628280-23-038169.md) | [4.5](/filings/0001692787-25-000007.md) | [9.8](/filings/0001692787-24-000034.md) | [12.5](/filings/0001692787-24-000042.md) | [20.4](/filings/0001692787-24-000052.md) | [3.6](/filings/0001692787-26-000048.md) | [8.8](/filings/0001692787-25-000027.md) | [10.7](/filings/0001692787-25-000050.md) | [7.7](/filings/0001692787-25-000067.md) | [4.0](/filings/0001692787-26-000116.md) | [0.7](/filings/0001692787-26-000092.md) | [7.8](/filings/0001692787-26-000116.md) |
| Current assets | $m | [288](/filings/0001628280-23-038169.md) | [257](/filings/0001692787-25-000007.md) | [257](/filings/0001692787-24-000034.md) | [299](/filings/0001692787-24-000042.md) | [286](/filings/0001692787-24-000052.md) | [295](/filings/0001692787-26-000048.md) | [315](/filings/0001692787-25-000027.md) | [313](/filings/0001692787-25-000050.md) | [315](/filings/0001692787-25-000067.md) | [302](/filings/0001692787-26-000116.md) | [319](/filings/0001692787-26-000092.md) | [350](/filings/0001692787-26-000116.md) |
| Total assets | $m | [6,286](/filings/0001628280-23-038169.md) | [6,497](/filings/0001692787-25-000007.md) | [6,448](/filings/0001692787-24-000034.md) | [6,860](/filings/0001692787-24-000042.md) | [6,860](/filings/0001692787-24-000052.md) | [6,815](/filings/0001692787-26-000048.md) | [7,031](/filings/0001692787-25-000027.md) | [7,151](/filings/0001692787-25-000050.md) | [7,202](/filings/0001692787-25-000067.md) | [7,096](/filings/0001692787-26-000116.md) | [7,111](/filings/0001692787-26-000092.md) | [7,202](/filings/0001692787-26-000116.md) |
| Current liabilities | $m | [251](/filings/0001628280-23-038169.md) | [250](/filings/0001692787-25-000007.md) | [234](/filings/0001692787-24-000034.md) | [399](/filings/0001692787-24-000042.md) | [399](/filings/0001692787-24-000052.md) | [419](/filings/0001692787-26-000048.md) | [475](/filings/0001692787-25-000027.md) | [502](/filings/0001692787-25-000050.md) | [504](/filings/0001692787-25-000067.md) | [441](/filings/0001692787-26-000116.md) | [537](/filings/0001692787-26-000092.md) | [512](/filings/0001692787-26-000116.md) |
| Total liabilities | $m | [3,916](/filings/0001628280-23-038169.md) | [3,870](/filings/0001692787-25-000007.md) | [3,796](/filings/0001692787-24-000034.md) | [3,778](/filings/0001692787-24-000042.md) | [3,798](/filings/0001692787-24-000052.md) | [3,836](/filings/0001692787-26-000048.md) | [4,130](/filings/0001692787-25-000027.md) | [4,341](/filings/0001692787-25-000050.md) | [4,577](/filings/0001692787-25-000067.md) | [4,165](/filings/0001692787-26-000116.md) | [4,269](/filings/0001692787-26-000092.md) | [4,290](/filings/0001692787-26-000116.md) |
| Long-term debt | $m | [3,630](/filings/0001628280-23-038169.md) | [3,594](/filings/0001692787-24-000052.md) | [3,547](/filings/0001692787-24-000034.md) | [3,287](/filings/0001692787-24-000042.md) | [3,307](/filings/0001692787-24-000052.md) | [3,390](/filings/0001692787-26-000048.md) | [3,595](/filings/0001692787-25-000027.md) | [3,765](/filings/0001692787-25-000050.md) | [3,983](/filings/0001692787-25-000067.md) | [3,653](/filings/0001692787-26-000116.md) | [3,668](/filings/0001692787-26-000092.md) | [3,723](/filings/0001692787-26-000116.md) |
| Current portion of debt | $m | not reported | [0.0](/filings/0001692787-25-000007.md) | not reported | [149](/filings/0001692787-24-000042.md) | [150](/filings/0001692787-24-000052.md) | [140](/filings/0001692787-26-000048.md) | [149](/filings/0001692787-25-000027.md) | [189](/filings/0001692787-25-000050.md) | [179](/filings/0001692787-25-000067.md) | [165](/filings/0001692787-26-000116.md) | [187](/filings/0001692787-26-000092.md) | [225](/filings/0001692787-26-000116.md) |
| Short-term borrowings | $m | not reported | [0.0](/filings/0001692787-24-000042.md) | not reported | [149](/filings/0001692787-24-000042.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [(838)](/filings/0001692787-24-000052.md) | [(531)](/filings/0001692787-26-000048.md) | [(973)](/filings/0001692787-25-000050.md) | [(1,207)](/filings/0001692787-25-000067.md) | [(1,721)](/filings/0001692787-25-000067.md) | [(2,977)](/filings/0001692787-26-000116.md) | [(2,550)](/filings/0001692787-26-000116.md) | [(1,566)](/filings/0001692787-26-000116.md) | [(1,776)](/filings/0001692787-25-000067.md) | [(565)](/filings/0001692787-26-000116.md) | [(1,669)](/filings/0001692787-26-000116.md) | [(1,185)](/filings/0001692787-26-000116.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:DebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [175 d](/filings/0001692787-24-000052.md) | [179 d](/filings/0001692787-26-000048.md) | [154](/filings/0001692787-25-000027.md) | [126 d](/filings/0001692787-25-000050.md) | [214 d](/filings/0001692787-25-000067.md) | [144 d](/filings/0001692787-26-000048.md) | [177](/filings/0001692787-26-000092.md) | [129 d](/filings/0001692787-26-000116.md) | [188 d](/filings/0001692787-25-000067.md) | [110 d](/filings/0001692787-26-000048.md) | [180](/filings/0001692787-26-000092.md) | [161 d](/filings/0001692787-26-000116.md) |
| Capital expenditure | $m | [85.6 d](/filings/0001692787-24-000052.md) | [67.1 d](/filings/0001692787-26-000048.md) | [58.0](/filings/0001692787-25-000027.md) | [39.4 d](/filings/0001692787-25-000050.md) | [58.5 d](/filings/0001692787-25-000067.md) | [108 d](/filings/0001692787-26-000048.md) | [74.5](/filings/0001692787-26-000092.md) | [127 d](/filings/0001692787-26-000116.md) | [157 d](/filings/0001692787-25-000067.md) | [134 d](/filings/0001692787-26-000048.md) | [83.0](/filings/0001692787-26-000092.md) | [109 d](/filings/0001692787-26-000116.md) |
| Dividends paid | $m | [21.8 d](/filings/0001692787-24-000052.md) | [23.3 d](/filings/0001692787-26-000048.md) | [38.7](/filings/0001692787-25-000027.md) | [44.8 d](/filings/0001692787-25-000050.md) | [44.9 d](/filings/0001692787-25-000067.md) | [46.8 d](/filings/0001692787-26-000048.md) | [47.0](/filings/0001692787-26-000092.md) | [48.0 d](/filings/0001692787-26-000116.md) | [48.6 d](/filings/0001692787-25-000067.md) | [50.2 d](/filings/0001692787-26-000048.md) | [52.3](/filings/0001692787-26-000092.md) | [59.9 d](/filings/0001692787-26-000116.md) |
| Share repurchases | $m | [0.0 d](/filings/0001692787-24-000052.md) | [0.0 d](/filings/0001692787-26-000048.md) | [0.0](/filings/0001692787-24-000034.md) | [0.0 d](/filings/0001692787-25-000050.md) | [0.0 d](/filings/0001692787-25-000067.md) | [0.0 d](/filings/0001692787-26-000048.md) | not reported | not reported | [100 d](/filings/0001692787-25-000067.md) | [3.5 d](/filings/0001692787-26-000048.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [41.9](/filings/0001628280-23-038169.md) | [47.8](/filings/0001692787-24-000034.md) | [50.6](/filings/0001692787-24-000042.md) | [53.5](/filings/0001692787-24-000052.md) | [58.4](/filings/0001692787-25-000027.md) | [60.3](/filings/0001692787-25-000050.md) | [60.4](/filings/0001692787-25-000067.md) | [61.0](/filings/0001692787-26-000092.md) | [62.2](/filings/0001692787-26-000116.md) | [62.4](/filings/0001692787-25-000067.md) | [66.7](/filings/0001692787-26-000092.md) | [75.8](/filings/0001692787-26-000116.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.